"Burjeel Holding" New horizons open to send the first astronaut with diabetes to space
New York, September 26 / WAM / Burjeel Holding, the leading company in the highly specialized health care sector in the Middle East and North Africa region, in cooperation with Axium Space, specialized in human space flights, announced the preliminary results of its advanced scientific research, Sweet Ride, which took place on the International Space Station during the Axium 4-AX-4 mission, in the framework of opening new horizons to send the first injured astrology pioneer Diabetes to space.
The results were revealed during a special ceremony hosted by the Burjeel International Health Institute in New York, in the presence of His Excellency Imran Sharaf, Assistant Minister of Foreign Affairs and International Cooperation for Advanced Science and Technology, and Dr. Shamshir Faylail, founder and chairman of the Board of Directors of “Burjeel Holding”, along with a group of international experts in space and health care.
During the “AX-4” mission, a crew of four individuals spent 18 days in the absence of gravity to carry out experiments, as an integrated package of health care possibilities was sent away.
Through this, the Sweet Ride initiative explored the mechanisms of diabetes management in space, in a revolutionary step aimed at enabling persons with special medical conditions to go into space flights.
The results revealed that the “CGMS”, which are wearable devices to measure blood sugar levels, in addition to insulin pens, have proven their ability to work efficiently in harsh space conditions, and data also showed that the accuracy of “CGM” devices in the space matches their results on Earth, with the possibility of probing readings to follow -up centers on Earth.
His Excellency Imran Sharaf said, during his participation in the discussion session, that the future of space exploration should be based on the principle of “comprehensive space” that opens the door for all individuals without exception, stressing that the difference in health needs between humans, resulting from their genetic diversity, requires the development of innovative solutions that take into account these differences.
He added that the accelerating increase in the number of travelers to space makes it necessary to take advantage of the recently tested technologies there, because of the rich scientific data that enhances knowledge and pushes the march of scientific research to new horizons, indicating that the expected impact of these efforts will be wide and unprecedented.
For his part, Dr. Mohamed Fatyan, medical director in Burjeel Medical City, President of Satellite Health Research, confirmed that the “Barjeel Holding” initiative came to put a pioneering imprint in the field of space medicine, in line with the aspirations of the UAE.
He explained that this study is not limited to enabling astronauts with diabetes to go through the experiment, but rather extends to a fundamental shift in the methods of providing health care on the ground.
He added that the results open the way for the adoption of innovative models for health care, which can be applied in the most difficult conditions, whether at an altitude of 250 miles in space or at sea on oil platforms, in order to enhance the future of advanced medicine and make health services more comprehensive and effective.
This achievement embodies a qualitative shift for the UAE, as the study demonstrated the possibility of using daily diabetes treatment tools, on which millions of patients depend on the Earth, to accurately follow up on the disease in the space environment, while this research is a strategic step that enables future astronauts with diabetes to join space missions, and also opens wide horizons for innovation of advanced solutions in the field of health care for a dimension, It connects the Earth and the space with high flexibility.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
